Healthcare & Pharmaceuticals
- Healthcare & Pharmaceuticals · December 22, 2021 · 11:29 PM UTCU.S. authorizes Pfizer oral COVID-19 treatment, first for at-home use
The United States on Wednesday authorized Pfizer Inc's antiviral COVID-19 pill for people ages 12 and older at risk of severe illness, the first oral and at-home treatment as well as a new tool against the fast-spreading Omicron variant.
- United StatesU.S. testing struggles to keep up with Omicron
- Healthcare & PharmaceuticalsScotland reports fewer COVID-19 hospitalizations with Omicron
- Healthcare & PharmaceuticalsHospital stay risk for Omicron is 40%-45% lower than Delta -UK study
- Healthcare & PharmaceuticalsNovavax says COVID vaccine triggers immune response to Omicron variant
- Healthcare & PharmaceuticalsVenezuela's Maduro says seven Omicron cases detected
- Healthcare & PharmaceuticalsEXCLUSIVE Vaccine maker Serum waives AstraZeneca shot indemnity for refugee programme
- Healthcare & Pharmaceuticals'Significant increase' in protection vs Omicron from mRNA boosters, study says
- Healthcare & PharmaceuticalsMexico reports 198 more COVID-19 fatalities; death toll reaches 298,359
- Healthcare & PharmaceuticalsCommon health issues raise risk for severe COVID-19; sudden food aversion in toddlers may be due to COVID